PE48297A1 - METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISORDERS - Google Patents

METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISORDERS

Info

Publication number
PE48297A1
PE48297A1 PE1996000327A PE00032796A PE48297A1 PE 48297 A1 PE48297 A1 PE 48297A1 PE 1996000327 A PE1996000327 A PE 1996000327A PE 00032796 A PE00032796 A PE 00032796A PE 48297 A1 PE48297 A1 PE 48297A1
Authority
PE
Peru
Prior art keywords
prevention
gastrointestinal disorders
compositions
treatment
methods
Prior art date
Application number
PE1996000327A
Other languages
Spanish (es)
Inventor
Jamesina Anne Fitzgerald
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE48297A1 publication Critical patent/PE48297A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

REFERIDOS AL USO DE APROXIMADAMENTE 50 A 5000 MILIGRAMOS DE BISMUTO AL DIA, POR APROXIMADAMENTE DE 1 A 56 DIAS; Y DE APROXIMADAMENTE 100 A 10000 MILIGRAMOS DE CADA UNO DE UNO O MAS ANTIMICROBICOS AL DIA, POR APROXIMADAMENTE 1 A 21 DIAS; EL PRESENTE INVENTO TAMBIEN SE REFIERE A UN METODO DE PREVENCION DE DESORDENES GASTROINTESTINALES EN HUMANOS O ANIMALES MENORES, CAUSADOS O TRASMITIDOS POR UNO O MAS PROTOZOOS PARASITARIOSREFERRED TO THE USE OF APPROXIMATELY 50 TO 5000 MILLIGRAMS OF BISMUTE PER DAY, FOR APPROXIMATELY 1 TO 56 DAYS; AND FROM APPROXIMATELY 100 TO 10,000 MILLIGRAMS OF EACH ONE OF ONE OR MORE ANTIMICROBICS A DAY, FOR APPROXIMATELY 1 TO 21 DAYS; THE PRESENT INVENTION ALSO REFERS TO A METHOD OF PREVENTION OF GASTROINTESTINAL DISORDERS IN HUMANS OR MINOR ANIMALS, CAUSED OR TRANSMITTED BY ONE OR MORE PARASITIC PROTOZOA

PE1996000327A 1995-05-09 1996-05-08 METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISORDERS PE48297A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43747595A 1995-05-09 1995-05-09

Publications (1)

Publication Number Publication Date
PE48297A1 true PE48297A1 (en) 1998-02-04

Family

ID=23736610

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1996000327A PE48297A1 (en) 1995-05-09 1996-05-08 METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISORDERS

Country Status (6)

Country Link
EP (1) EP0830135A1 (en)
JP (1) JPH11504940A (en)
AU (1) AU5733696A (en)
CA (1) CA2219758A1 (en)
PE (1) PE48297A1 (en)
WO (1) WO1996035436A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2791888B1 (en) * 1999-04-06 2004-10-08 Ethypharm Lab Prod Ethiques ORAL PHARMACEUTICAL SUSPENSION
BR0009557A (en) 1999-04-06 2002-05-28 Ethypharm Lab Prod Ethiques Pharmaceutical suspension for ibuprofen drinking
US10335390B2 (en) 2014-09-05 2019-07-02 Symbiomix Therapeutics, Llc Secnidazole for use in the treatment of bacterial vaginosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU590578B2 (en) * 1985-04-18 1989-11-09 Procter & Gamble Company, The Treatment of non-ulcer dyspepsia with bismuth salts
DE3650787T2 (en) * 1985-06-13 2006-11-16 Dr. Barry James Marshall A pharmaceutical composition for the treatment of gastrointestinal disorders containing bismuth and an antimicrobial agent
DE3887353T2 (en) * 1987-10-12 1994-05-05 Exomed Australia Pty Ltd TREATMENT PROCEDURE FOR STOMACH-DISEASES.
DE59309771D1 (en) * 1993-05-11 1999-10-14 Spirig Ag Solid bismuth and amoxycillin medicinal product and its use

Also Published As

Publication number Publication date
JPH11504940A (en) 1999-05-11
WO1996035436A1 (en) 1996-11-14
CA2219758A1 (en) 1996-11-14
EP0830135A1 (en) 1998-03-25
AU5733696A (en) 1996-11-29

Similar Documents

Publication Publication Date Title
TR200102021T2 (en) TWEAK and TWEAK receptor antagonists and their use for the treatment of immunological disorders
DE69625518T2 (en) ACTIVE SUBSTANCE FOR TREATING NEURODEGENERATIVE DISORDERS
IS4819A (en) Innovative substituted cyclic amino acids used for pharmaceutical purposes
ATE284690T1 (en) ANTITHRBOTIC DIAMINE
YU67694A (en) NON-PEPTIDE ANTAGOSISTS OF TAHIKININ RECEPTORS
BR9908869A (en) Composition to prevent or treat skin disorders
DK1196397T3 (en) Metabotropic glutamate receptor antagonists and their use in the treatment of central nervous system disorders
ES2194960T3 (en) N- (2-SUBSTITUTED-3- (2-AMINOETIL) -1H-INDOL-5-IL) -AMIDAS AS NEW AGONISTS OF 5-HT1F.
DE60229530D1 (en) SUBSTITUTED PIPERAZINE AS MODULATORS OF MELANOCORTINRECEPTOR
DE60228073D1 (en) ADENOSINE A1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF HYPOXINE LEARNING AND MEMORY DISORDERS
NO983612D0 (en) Novel cyclic amino acids as pharmaceutical agents
MX9203050A (en) TRIPTAMINE ANALOG COMPOUNDS.
DE69921340D1 (en) BRANCHED ALKYLPYRROLIDIN-3-CARBONIC ACIDS
FI961809A (en) Novel (R) -5-carbamoyl-8-fluoro-3-N, N-disubstituted amino 3,4-dihydro-2H-1-benzopyrans
NO944578L (en) Excitatory amino acid receptor antagonists
NO976048L (en) Pharmaceutical and diet formulations for prophylaxis and treatment of gastrointestinal disorders
AR028705A1 (en) BIS-ARILSULPHONES
HUP9800731A2 (en) Stimulation of meiosis
BR0010183A (en) Monofluoroalkyl derivatives
DK0989973T3 (en) Chalcones with antiproliferative activity
PE48297A1 (en) METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISORDERS
DK0996435T3 (en) Amino acid derivatives useful for the treatment of stroke
ATE298742T1 (en) CYCLOALKENYLSULFONAMIDE DERIVATIVES
DE69617956D1 (en) COMPOSITIONS WHICH HAVE ADP-RIBOSYL TRANSFERASE ACTIVITY AND METHODS FOR THEIR PRODUCTION AND USE
PT950056E (en) N- (PYRIDINYLAMINO) ISOINDOLINS AND RELATED COMPOUNDS

Legal Events

Date Code Title Description
FA Abandonment or withdrawal